Current Cancer Drug Targets, Volume 16 - Number 8


Editorial (Thematic Issue: Pathogenetic Mechanisms of CLL - A Target in Therapy)

, 16(8): 651

Maria Bozko, Monika Podhorecka, Arkadiusz Macheta, Andrzej Bozko, Nisar P. Malek and Przemyslaw Bozko

DOI: 10.2174/156800961608160902101746

Review Article

Deregulation of Apoptosis - Is it Still an Important Issue in Pathogenesis of Chronic Lymphocytic Leukemia?

, 16(8): 652 - 658

Monika Podhorecka, Arkadiusz Macheta, Maria Bozko, Andrzej Bozko, Nisar P. Malek and Przemyslaw Bozko

DOI: 10.2174/1568009616666160427103930

Review Article

Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia

, 16(8): 659 - 668

Michele Dal Bo, Erika Tissino, Dania Benedetti, Chiara Caldana, Riccardo Bomben, Giovanni Del Poeta, Gianluca Gaidano, Francesca Maria Rossi, Pietro Bulian, Antonella Zucchetto and Valter Gattei

DOI: 10.2174/1568009616666160809102219

Review Article

Targeting Signaling Pathways in Chronic Lymphocytic Leukemia

, 16(8): 669 - 688

Alice F. Muggen, Simar P. Singh, Rudi W. Hendriks and Anton W. Langerak

DOI: 10.2174/1568009616666160408145623

Review Article

Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia

, 16(8): 689 - 700

John C. Riches and John G. Gribben

DOI: 10.2174/1568009616666160408145741

Review Article

Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge

, 16(8): 701 - 709

Lukas Smolej

DOI: 10.2174/1568009616666160408150032

Review Article

Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions

, 16(8): 710 - 720

Lukas Smolej

DOI: 10.2174/1568009616666160408145850

Research Article

Proteomic and Metabolic Signatures of Esophageal Squamous Cell Carcinoma

, 16(8): 721 - 736

Kubra Karagoz, Heather L. Lehman, Douglas B. Stairs, Raghu Sinha and Kazim Y. Arga

DOI: 10.2174/1568009616666160203113721

Webmaster Contact:
Copyright © 2018 Bentham Science